The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pertussis Vaccine Market Research Report 2025
Synopsis
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccine market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6619.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
Report Scope
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Segment by Type
Whole-cell Vaccines
Acellular Vaccines
Segment by Application
12 Months Below
12 Months Above
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccine market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6619.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
Report Scope
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Segment by Type
Whole-cell Vaccines
Acellular Vaccines
Segment by Application
12 Months Below
12 Months Above
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pertussis Vaccine Market Overview
1.1 Product Overview and Scope of Pertussis Vaccine
1.2 Pertussis Vaccine Segment by Type
1.2.1 Global Pertussis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Pertussis Vaccine Segment by Application
1.3.1 Global Pertussis Vaccine Market Value by Application: (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Pertussis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pertussis Vaccine Revenue 2019-2030
1.4.2 Global Pertussis Vaccine Sales 2019-2030
1.4.3 Global Pertussis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pertussis Vaccine Market Competition by Manufacturers
2.1 Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pertussis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Pertussis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertussis Vaccine, Product Type & Application
2.7 Pertussis Vaccine Market Competitive Situation and Trends
2.7.1 Pertussis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pertussis Vaccine Players Market Share by Revenue
2.7.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pertussis Vaccine Retrospective Market Scenario by Region
3.1 Global Pertussis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pertussis Vaccine Global Pertussis Vaccine Sales by Region: 2019-2030
3.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
3.2.2 Global Pertussis Vaccine Sales by Region: 2025-2030
3.3 Global Pertussis Vaccine Global Pertussis Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pertussis Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pertussis Vaccine Revenue by Region: 2025-2030
3.4 North America Pertussis Vaccine Market Facts & Figures by Country
3.4.1 North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pertussis Vaccine Sales by Country (2019-2030)
3.4.3 North America Pertussis Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pertussis Vaccine Market Facts & Figures by Country
3.5.1 Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pertussis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pertussis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pertussis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pertussis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pertussis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pertussis Vaccine Sales by Type (2019-2030)
4.1.1 Global Pertussis Vaccine Sales by Type (2019-2024)
4.1.2 Global Pertussis Vaccine Sales by Type (2025-2030)
4.1.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pertussis Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pertussis Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pertussis Vaccine Sales by Application (2019-2030)
5.1.1 Global Pertussis Vaccine Sales by Application (2019-2024)
5.1.2 Global Pertussis Vaccine Sales by Application (2025-2030)
5.1.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pertussis Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pertussis Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Corporation Information
6.4.2 Wuhan Institute of Biological Products Description and Business Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Corporation Information
6.6.2 Minhai Biotechnology Description and Business Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
6.6.5 Minhai Biotechnology Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Pertussis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 Chengdu Institute of Biological Products
6.8.1 Chengdu Institute of Biological Products Corporation Information
6.8.2 Chengdu Institute of Biological Products Description and Business Overview
6.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertussis Vaccine Industry Chain Analysis
7.2 Pertussis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertussis Vaccine Production Mode & Process
7.4 Pertussis Vaccine Sales and Marketing
7.4.1 Pertussis Vaccine Sales Channels
7.4.2 Pertussis Vaccine Distributors
7.5 Pertussis Vaccine Customers
8 Pertussis Vaccine Market Dynamics
8.1 Pertussis Vaccine Industry Trends
8.2 Pertussis Vaccine Market Drivers
8.3 Pertussis Vaccine Market Challenges
8.4 Pertussis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
